Thighplasty

A Thighplasty procedure, also known as a Thigh Lift procedure or a Thigh Contouring procedure, is intended to lift and reshape thigh skin that is unattractively saggy and dimpled. Many candidates for a Thighplasty procedure have excess skin as a result of weight loss, or simply because of the natural effects of aging. A Thighplasty procedure removes excess fat and skin from the inner and outer thighs to create a tighter, firmer, more toned thigh appearance.

There are a number of different ways to perform Thighplasty surgery, depending on the areas of concern.
Inner (or Medial) Thigh Lift - The inside of the thighs are very difficult to shape through exercise. An Inner Thigh Lift procedure involves an incision along the junction between the thigh and pubic area and removal of loose skin, and if necessary fat.
Outer (or Lateral) Thigh Lift - This procedure tightens the skin on the front and outside of the thigh.
Inner (Medial) Thigh Lift with Liposuction - This procedure tightens the skin at the top of the inner thigh; the effects do extend further down the inner thigh than a lift alone lift.

A Thighplasty procedure is a major cosmetic surgery procedure. All Thighplasty procedures are performed under a general anaesthetic. When the Thighplasty procedure is combined with a liposuction procedure, the entire process can take from two to four hours, but it really depends on the individual patient as well as the situation. The incision is very inconspicuous and is located in the groin beneath the bikini line. It has a tendency to heal slightly wide and dark but this gets better over time.

Drains are used for two days. These are soft and comfortable and removed without pain. You can shower on the second or third day after surgery after the drains are out. Dressings and a light compression garment are used for several days. The stitches are removed at ten days.

The Thighplasty procedure can be combined with other plastic surgical procedures. Such as a Buttock Lift, Liposuction, Tummy Tuck, or Breast Lift procedure.

After recovery from a Thighplasty procedure, the patient can go home after several hours, but it is more comfortable to stay overnight. The patient should plan on taking at least 3 weeks off work. You will feel tired and sore for 3 to 7 days after surgery. A compression garment is worn continuously for 2 to 3 weeks, and then at night for a further 2 to 3 weeks. This will help define the new contour of your thighs.
Activities that increase your heart rate above 100 beats per minute for 3 weeks are not recommended.

All surgical procedures carry a risk of infection, bleeding, and reaction to anesthesia. Specific Thighplasty risks can include scarring, nerve injury, and tissue damage.

The result of a Thighplasty procedure is beautiful, tightened, lifted and flattened contour to the thighs. A more confident and comfortable feeling in clothing, especially sports wear and jeans. If there is continued sagging or weight loss, then a second touch up procedure can help. A natural and presentable appearance in the first week that just gets better over the next three to six months.

More Calgary info...


  • Calgary By car
    Many people can be confused or lost when they first drive around in Calgary. Not because the streets are confusing, but rather because Calgary is laid out into four quadrants (North-East, South-East, South-West and North-West) and the type of road (Street or Avenue) matters in terms of direction (streets go north-south, avenues go east-west). Once you understand the layout of the city, you will find it very easy to navigate.

    Calgary is divided into its quadrants at Centre Ave and Centre St. Being north of Centre Ave means you are in the northern quadrants and being east of Centre St means you are in the eastern quadrants. All street and avenue numbers radiate out from centre so being on 17th ave SW is fairly close to centre while being on 52nd St NE is not.
    -


  • Calgary By plane
    Calgary International Airport, [2]. Calgary International has four terminals (A,B,C,D). It is well laid out and easy to find your way around.
    WestJet, [3]. Canada's main discount airline makes its hub here.
    Air Canada, [4]. The national carrier uses Calgary International as a secondary hub.
    British Airways, [5]. Five flights a week to London. -

Plastic Surgery News...

  • A study to assess the adverse effects of anti-retroviral drugs shows that two widely-used HIV drugs are associated with an increased risk of heart attack / the formation of blood clots in the heart. With the use of Didanosine, the risk of developing a heart attack increases by 49%, with Abacavir; the increased risk is 90%.

  • The National Institute for Health and Clinical Excellence (NICE) has published an appraisal consultation document (ACD – draft guidance) on the use of alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. The guidance recommends (direct from source): 1.1 Alendronate is recommended as a treatment option for the secondary prevention of osteoporotic fragility fractures in postmenopausal women who have a T-score of -2.5 SD or below. In women aged 75 years or older, a DXA scan may not be required if the responsible clinician considers it to be clinically inappropriate or unfeasible. When the decision has been made to initiate treatment with alendronate, the preparation prescribed should be chosen on the basis of the lowest acquisition cost available. 1.2 Risedronate and etidronate are recommended as alternative treatment options for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: • who are unable to comply with the special instructions for the administration of alendronate, have a contraindication to, or are intolerant of alendronate (as defined in section 1.7) and • who also have a T-score, age and number of independent clinical risk factors for fracture (see section 1.5) - please refer to table in the ACD for T-scores (SD) at (or below) which risedronate or etidronate is recommended. 1.3 Raloxifene and strontium ranelate are recommended as alternative treatment options for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: • who are unable to comply with the special instructions for the administration of alendronate and risedronate, or who have a contraindication to or are intolerant of alendronate and risedronate (as defined in section 1.6) and • who also have a T-score, age and number of independent clinical risk factors for fracture (see section 1.5) - please refer to table in the ACD for T-scores (SD) at (or below) which raloxifene or strontium ranelate is recommended. 1.4 Teriparatide is recommended as an alternative treatment option for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: • who are unable to take alendronate and risedronate, have a contraindication to, or are intolerant of alendronate and risedronate (as defined in section 1.6) or who have a contraindication to, or are intolerant of strontium ranelate (as defined in section 1.7) and • who are 65 years or older and have an extremely low BMD (with a T-score of -4 SD or below), or a very low BMD (with a T-score of -3.5 SD or below) plus multiple fractures (that is, more than two), or who are aged 55-64 years and have a T-score of -4 SD or below plus multiple fractures (that is, more than two). 1.5 For the purposes of this guidance, independent clinical risk factors for fracture to be considered are: parental history of hip fracture, alcohol intake of 4 or more units per day, and severe, long-term rheumatoid arthritis. 1.6 For the purposes of this guidance, intolerance of alendronate and risedronate is defined as persistent upper gastrointestinal disturbance that is sufficiently severe to warrant discontinuation of treatment and that occurs even though the instructions for administration have been followed correctly. 1.7 For the purpose of this guidance, intolerance of strontium ranelate is defined as persistent nausea or diarrhoea, either of which warrants discontinuation of treatment. 1.8 Women who are currently receiving treatment with one of the drugs covered by this guidance, but for whom therapy would have not been recommended according to sections 1.1 to 1.4, should have the option to continue therapy until they and their clinicians consider it appropriate to stop. The key dates for this appraisal are: Closing date for comments: 23 April 2008 Second Appraisal Committee meeting: 01 May 2008

Ask A Local Surgeon
From Calgary

»Have a Local Immersivemedical member contact you«

Plastic Surgery Articles


»Add Your Article«

Find More Thighplasty procedures in CA


Buttock Implants in Calgary, Eyelid Surgery in Calgary, Body Contouring in Calgary, Botox® Cosmetic in Calgary, Breast Augmentation in Calgary, Breast Reduction in Calgary, Buttock Augmentation in Calgary, Chemical Peel in Calgary, Chin Augmentation in Calgary, Correction Of Breast Asymmetry in Calgary, Ear Surgery in Calgary, Facelift in Calgary, Fat Grafting in Calgary, Gastric Bypass in Calgary, Hair Replacement in Calgary, Jaw Surgery in Calgary, Lip Augmentation in Calgary, Liposuction in Calgary, Male Breast Reduction in Calgary, Neck Lift in Calgary, Penis Enlargement in Calgary, Spider Vein Treatment in Calgary, Breast Reconstruction in Calgary, Nose Reshaping in Calgary, Dermabrasion in Calgary, Vaginal Surgery in Calgary, Medical Tourism in Calgary, Plastic Surgeon in Calgary, Arm Lift in Calgary, Tummy Tuck in Calgary, Hyperhydrosis in Calgary, Nose Surgery in Calgary, Hair Transplant in Calgary, Cellulite Treatment in Calgary, Hair Removal in Calgary, Tattoo Removal in Calgary, Cheek Augmentation in Calgary, Inverted Nipple Repair in Calgary, Skin Resurfacing in Calgary, Body Procedures in Calgary, Permanent Cosmetics in Calgary, Face Procedures in Calgary, Skin Surgery1 in Calgary, Calf Augmentation in Calgary, Birthmark Removal in Calgary